Skip to main content
Premium Trial:

Request an Annual Quote

BBSRC, UK Partners Launch Start-up Home

NEW YORK (GenomeWeb News) – The UK government's bioscience funding arm and regional development agencies in Norwich are building a new £5 million ($8.1 million) facility at the Norwich Research Park (NRP) that will provide lab space that researchers can use to translate their discoveries into commercially viable technologies.

The Biotechnology and Biological Sciences Research Council (BBSRC) will contribute the land and buildings to host the new facilities, along with £500,000.

The East of England Development Agency will chip in £1.4 million, the Greater Norwich Development Partnership will add £1 million, and the University of East Anglia will chip in £500,000. The remainder of the funding will come from other NRP partners.

The NRP includes several partners, including the University of East Anglia (UAE), Norfolk and Norwich University Hospital, and four research centers, including The Genome Analysis Centre, the Institute of Food Research, the John Innes Centre, and the Institute of Food Research (IFR).

The facility will be managed by the BBSRC, the IFR, and the UAE, as well as a new joint venture company called Colney Innovations (CIL).

"This new facility will play a key role in helping our scientists, and others, to translate their excellent science into products, services, advice, and jobs to benefit the economy and people of the UK," BBSRC's Chief Executive, Douglas Kell, said in a statement.

"The office and laboratory suites will provide unrivalled facilities for new and expanding research businesses attracted to the cluster of science facilities at the Norwich Research Park," BBSRC's Director of Finance and CIL's Director David Parfrey added.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.